Bayes in America

<img src=“Bayes2020.png”, width = “600”, height = “1200” style=“float: right;margin-left: 20px;margin-top: 0px;margin-bottom:0px;">

For the first time ever, the annual Bayes 20XX/Bayesian Biostatistics is going to be held outside Europe — in fact we’re going to be in Washington DC.

It will be an unusual edition — the timing is also very different; normally we have the workshop late May/early June. But this year we’ve defered it to late September to more or less fit with other conferences happening at the FDA. We’ve made a big effort in creating stronger links with the regulators (and the Americans, in particular), so this is certainly a great result for our “Founding Father” Bruno Boulanger!

As usual we have several topics of interest, including the following.

• The future of the Bayesian Biostatistics in the regulatory world

• Clinical Innovative Design

• Bayesian biostatistics for Real World Evidence (RWE)

• Rare and orphan disease, pediatric development

• Preventive medicine

• Meta-analyses, prior elicitation, historical controls, meta-analyses

• Reproducibility crisis & related topics such as DoE, Assurance (Success…)

• Non-Clinical Statistics, CMC and related topics (QbD, Stability, bioassays, validation, …)

• Multivariate models

• Bayesian inference in complex models (systems biology / PBPK / networks)

• Bayesian Spatio-temporal/Temporal modelling (e.g. disease propagation, survival analysis,…)

• Bayesian Decision sciences

• Benefit/Risk analyses, health economics

• Bayesian Big Data, predictive models, selection of variables

• Programming and numerical opportunities

• Communication of Bayesian statistics

Registrations and call for abstract to open soon!